EyePoint (EYPT) Capital Expenditures (2010 - 2026)
EyePoint (EYPT) reported Capital Expenditures of $99000.0 for Q1 2026, up 125.0% on a YoY basis from $44000.0 in Q1 2025, and down 96.9% sequentially from $3.2 million in Q4 2025.
EyePoint (EYPT) Capital Expenditures (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Capital Expenditures data on file, last reported at $99000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 125.0% year-over-year to $99000.0; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (down 6.35% YoY), and the FY2025 full-year result was $3.3 million, down 19.05% from the prior year.
- Capital Expenditures declined to $99000.0 in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $3.2 million in Q4 2025 to a low of -$484000.0 in Q2 2023.
- A 5-year average of $638733.3 and a median of $218000.0 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures soared 814.5% in 2022 and plunged 322.02% in 2023, its largest moves.
- Tracing EYPT's Capital Expenditures over 5 years: stood at $585000.0 in 2022, then slumped by 182.74% to -$484000.0 in 2023, then jumped by 436.78% to $1.6 million in 2024, then jumped by 95.95% to $3.2 million in 2025, then tumbled by 96.9% to $99000.0 in 2026.
- Business Quant data shows EYPT's Capital Expenditures at $99000.0 in Q1 2026, $3.2 million in Q4 2025, and $24000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,000.00 |
| Mar 31, 2026 | 99,000.00 |
| Dec 31, 2025 | 3.19 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 1.63 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | -315,000.00 |
| Jun 30, 2024 | -315,000.00 |
| Mar 31, 2024 | 535,000.00 |
| Mar 31, 2024 | 535,000.00 |
| Jun 30, 2023 | -484,000.00 |
| Jun 30, 2023 | -484,000.00 |